ALIGNMENT HEALTHCARE ($ALHC) posted quarterly earnings results on Thursday, October 30th. The company reported earnings of $0.02 per share, beating estimates of -$0.08 by $0.10. The company also reported revenue of $993,700,000, missing estimates of $1,000,978,948 by $-7,278,948.
You can see Quiver Quantitative's $ALHC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ALIGNMENT HEALTHCARE Insider Trading Activity
ALIGNMENT HEALTHCARE insiders have traded $ALHC stock on the open market 42 times in the past 6 months. Of those trades, 0 have been purchases and 42 have been sales.
Here’s a breakdown of recent trading of $ALHC stock by insiders over the last 6 months:
- ATLANTIC, L.P. GENERAL has made 0 purchases and 3 sales selling 36,706,096 shares for an estimated $575,254,596.
- ATLANTIC (ALN HLTH), L.P. GENERAL has made 0 purchases and 3 sales selling 36,706,096 shares for an estimated $575,254,596.
- JOHN E KAO (Chief Executive Officer) has made 0 purchases and 9 sales selling 1,345,018 shares for an estimated $20,945,557.
- DAWN CHRISTINE MARONEY (President) has made 0 purchases and 8 sales selling 335,662 shares for an estimated $5,270,405.
- HYONG KIM (Chief Medical Officer) has made 0 purchases and 5 sales selling 147,034 shares for an estimated $2,431,524.
- ROBERT L. SCAVO (Chief Information Officer) has made 0 purchases and 4 sales selling 130,398 shares for an estimated $1,981,855.
- JOSEPH S KONOWIECKI has made 0 purchases and 4 sales selling 91,076 shares for an estimated $1,536,074.
- CHRISTOPHER J JOYCE (Chief Legal and Admin. Officer) has made 0 purchases and 4 sales selling 71,430 shares for an estimated $1,177,413.
- ANDREAS P. WAGNER (Chief Human Resources Officer) has made 0 purchases and 2 sales selling 31,431 shares for an estimated $494,209.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ALIGNMENT HEALTHCARE Hedge Fund Activity
We have seen 161 institutional investors add shares of ALIGNMENT HEALTHCARE stock to their portfolio, and 86 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GENERAL ATLANTIC, L.P. removed 17,000,000 shares (-27.9%) from their portfolio in Q2 2025, for an estimated $238,000,000
- CITADEL ADVISORS LLC added 8,079,612 shares (+3307.7%) to their portfolio in Q2 2025, for an estimated $113,114,568
- MILLENNIUM MANAGEMENT LLC added 3,843,445 shares (+162.7%) to their portfolio in Q2 2025, for an estimated $53,808,230
- DURABLE CAPITAL PARTNERS LP removed 3,589,745 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $50,256,430
- WELLINGTON MANAGEMENT GROUP LLP removed 3,359,607 shares (-44.7%) from their portfolio in Q2 2025, for an estimated $47,034,498
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 3,253,607 shares (+35.8%) to their portfolio in Q2 2025, for an estimated $45,550,498
- INVESCO LTD. added 2,294,739 shares (+122.3%) to their portfolio in Q2 2025, for an estimated $32,126,346
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ALIGNMENT HEALTHCARE Analyst Ratings
Wall Street analysts have issued reports on $ALHC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Goldman Sachs issued a "Buy" rating on 10/14/2025
To track analyst ratings and price targets for ALIGNMENT HEALTHCARE, check out Quiver Quantitative's $ALHC forecast page.
ALIGNMENT HEALTHCARE Price Targets
Multiple analysts have issued price targets for $ALHC recently. We have seen 3 analysts offer price targets for $ALHC in the last 6 months, with a median target of $21.0.
Here are some recent targets:
- Scott Fidel from Goldman Sachs set a target price of $21.0 on 10/14/2025
- Matthew Gillmor from Keybanc set a target price of $21.0 on 08/25/2025
- Andrew Mok from Barclays set a target price of $13.0 on 07/31/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
